TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Affinity DataIC50: 0.5nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2:3PS peptide as substrate preincubated for 15 mins followed by ATP addition at Km concentration an...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Affinity DataIC50: 0.5nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2:3PS peptide as substrate preincubated for 15 mins followed by ATP addition at Km concentration an...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Affinity DataIC50: 0.600nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2:3PS peptide as substrate preincubated for 15 mins followed by ATP addition at Km concentration an...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Affinity DataIC50: 1.10nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2:3PS peptide as substrate preincubated for 15 mins followed by ATP addition at Km concentration an...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Affinity DataIC50: 1.10nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2:3PS peptide as substrate preincubated for 15 mins followed by ATP addition at Km concentration an...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Affinity DataIC50: 1.20nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2:3PS peptide as substrate preincubated for 15 mins followed by ATP addition at Km concentration an...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Affinity DataIC50: 1.70nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2:3PS peptide as substrate preincubated for 15 mins followed by ATP addition at Km concentration an...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Affinity DataIC50: 1.80nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2:3PS peptide as substrate preincubated for 15 mins followed by ATP addition at Km concentration an...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Affinity DataIC50: 2nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2:3PS peptide as substrate preincubated for 15 mins followed by ATP addition at Km concentration an...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Affinity DataIC50: 2.10nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2:3PS peptide as substrate preincubated for 15 mins followed by ATP addition at Km concentration an...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Affinity DataIC50: 2.10nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2:3PS peptide as substrate preincubated for 15 mins followed by ATP addition at Km concentration an...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Affinity DataIC50: 2.30nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2:3PS peptide as substrate preincubated for 15 mins followed by ATP addition at Km concentration an...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Affinity DataIC50: 2.5nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2:3PS peptide as substrate preincubated for 15 mins followed by ATP addition at Km concentration an...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Affinity DataIC50: 2.70nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2:3PS peptide as substrate preincubated for 15 mins followed by ATP addition at Km concentration an...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Affinity DataIC50: 2.70nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2:3PS peptide as substrate preincubated for 15 mins followed by ATP addition at Km concentration an...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Affinity DataIC50: 3nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2:3PS peptide as substrate preincubated for 15 mins followed by ATP addition at Km concentration an...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Affinity DataIC50: 3.40nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2:3PS peptide as substrate preincubated for 15 mins followed by ATP addition at Km concentration an...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Affinity DataIC50: 3.5nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2:3PS peptide as substrate preincubated for 15 mins followed by ATP addition at Km concentration an...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Affinity DataIC50: 4.10nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2:3PS peptide as substrate preincubated for 15 mins followed by ATP addition at Km concentration an...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Affinity DataIC50: 4.30nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2:3PS peptide as substrate preincubated for 15 mins followed by ATP addition at Km concentration an...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Affinity DataIC50: 4.40nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2:3PS peptide as substrate preincubated for 15 mins followed by ATP addition at Km concentration an...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Affinity DataIC50: 4.90nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2:3PS peptide as substrate preincubated for 15 mins followed by ATP addition at Km concentration an...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Affinity DataIC50: 5.40nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2:3PS peptide as substrate preincubated for 15 mins followed by ATP addition at Km concentration an...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Affinity DataIC50: 5.5nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2:3PS peptide as substrate preincubated for 15 mins followed by ATP addition at Km concentration an...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Affinity DataIC50: 5.70nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2:3PS peptide as substrate preincubated for 15 mins followed by ATP addition at Km concentration an...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Affinity DataIC50: 6nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2:3PS peptide as substrate preincubated for 15 mins followed by ATP addition at Km concentration an...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Affinity DataIC50: 6.20nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2:3PS peptide as substrate preincubated for 15 mins followed by ATP addition at Km concentration an...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Affinity DataIC50: 6.90nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2:3PS peptide as substrate preincubated for 15 mins followed by ATP addition at Km concentration an...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Affinity DataIC50: 6.90nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2:3PS peptide as substrate preincubated for 15 mins followed by ATP addition at Km concentration an...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Affinity DataIC50: 8nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2:3PS peptide as substrate preincubated for 15 mins followed by ATP addition at Km concentration an...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Affinity DataIC50: 8.40nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2:3PS peptide as substrate preincubated for 15 mins followed by ATP addition at Km concentration an...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Affinity DataIC50: 8.40nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2:3PS peptide as substrate preincubated for 15 mins followed by ATP addition at Km concentration an...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Affinity DataIC50: 10nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2:3PS peptide as substrate preincubated for 15 mins followed by ATP addition at Km concentration an...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Affinity DataIC50: 12nMAssay Description:Inhibition of PI3Kalpha in human BT474 cells expressing P3KCA mutant assessed as reduction in AKT phosphorylation at residue S473 incubated for 2 hrs...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Affinity DataIC50: 12nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2:3PS peptide as substrate preincubated for 15 mins followed by ATP addition at Km concentration an...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Affinity DataIC50: 14nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2:3PS peptide as substrate preincubated for 15 mins followed by ATP addition at Km concentration an...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Affinity DataIC50: 19nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2:3PS peptide as substrate preincubated for 15 mins followed by ATP addition at Km concentration an...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Affinity DataIC50: 20nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2:3PS peptide as substrate preincubated for 15 mins followed by ATP addition at Km concentration an...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Affinity DataIC50: 20nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2:3PS peptide as substrate preincubated for 15 mins followed by ATP addition at Km concentration an...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Affinity DataIC50: 21nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2:3PS peptide as substrate preincubated for 15 mins followed by ATP addition at Km concentration an...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Affinity DataIC50: 23nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2:3PS peptide as substrate preincubated for 15 mins followed by ATP addition at Km concentration an...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Affinity DataIC50: 26nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2:3PS peptide as substrate preincubated for 15 mins followed by ATP addition at Km concentration an...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Affinity DataIC50: 26nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2:3PS peptide as substrate preincubated for 15 mins followed by ATP addition at Km concentration an...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Affinity DataIC50: 30nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2:3PS peptide as substrate preincubated for 15 mins followed by ATP addition at Km concentration an...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Homo sapiens (Human))
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Affinity DataIC50: 183nMAssay Description:Inhibition of PI3Kdelta in human Jeko1 cells assessed as reduction in AKT phosphorylation at residue S473 measured after 2 hrs by sandwich ELISAMore data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Affinity DataIC50: >1.00E+3nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2:3PS peptide as substrate preincubated for 15 mins followed by ATP addition at Km concentration an...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Homo sapiens (Human))
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Affinity DataIC50: 1.39E+3nMAssay Description:Inhibition of PI3Kbeta in human MDA-MB-468 cells assessed as reduction in AKT phosphorylation at residue S473 measured after 30 mins by sandwich ELIS...More data for this Ligand-Target Pair
TargetCytochrome P450 2C9(Homo sapiens (Human))
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Affinity DataIC50: 6.10E+3nMAssay Description:Inhibition of CYP2C9 in human liver microsomes using diclofenac as substrate preincubated for 10 mins followed by NADPH addition and measured after 1...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform(Mus musculus (Mouse))
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Affinity DataIC50: >1.00E+4nMAssay Description:Inhibition of PI3Kgamma in mouse RAW264.7 cells assessed as reduction in AKT phosphorylation at residue S473 treated with mouse C5a component and mea...More data for this Ligand-Target Pair
TargetCytochrome P450 2C19(Homo sapiens (Human))
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Luoxin Pharmaceutical (Shanghai) Co.
Curated by ChEMBL
Affinity DataIC50: 2.16E+4nMAssay Description:Inhibition of CYP2C19 in human liver microsomes using s-mephenytoin as substrate preincubated for 10 mins followed by NADPH addition and measured aft...More data for this Ligand-Target Pair